| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035387088 |
| P356 | DOI | 10.1038/SJ.ONC.1208300 |
| P698 | PubMed publication ID | 15608680 |
| P5875 | ResearchGate publication ID | 8120797 |
| P50 | author | Keitaro Matsuo | Q30506416 |
| Ritsuro Suzuki | Q73090383 | ||
| P2093 | author name string | Masao Seto | |
| Shigeo Nakamura | |||
| Yasuo Morishima | |||
| Xiaohua Zhang | |||
| Akinobu Ota | |||
| Sivasundaram Karnan | |||
| Hiroyuki Tagawa | |||
| P2860 | cites work | Bim: a novel member of the Bcl-2 family that promotes apoptosis | Q24532974 |
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes | Q28203083 | ||
| Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma | Q28260227 | ||
| Function of a human cyclin gene as an oncogene | Q34994859 | ||
| Mantle cell lymphoma is characterized by inactivation of the ATM gene | Q35081325 | ||
| API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products | Q35809909 | ||
| Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells | Q36371743 | ||
| Bim is a suppressor of Myc-induced mouse B cell leukemia | Q37647369 | ||
| Detection of t(11;18)(q21;q21) in marginal zone lymphoma of mucosa-associated lymphocytic tissue type on paraffin-embedded tissue sections by using fluorescence in situ hybridization | Q38453667 | ||
| Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization | Q38457830 | ||
| Establishment and characterization of a mantle cell lymphoma cell line | Q41006251 | ||
| Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions | Q51597461 | ||
| The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma | Q57279573 | ||
| t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia | Q73459806 | ||
| Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies | Q74098615 | ||
| Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray | Q74250057 | ||
| Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma | Q74480204 | ||
| Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma | Q77220569 | ||
| Comparison of genetic aberrations in CD10+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization | Q80906368 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphoma | Q208414 |
| mantle cell lymphoma | Q268713 | ||
| homozygosity | Q114049690 | ||
| P304 | page(s) | 1348-1358 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM | |
| P478 | volume | 24 |
| Q35134208 | A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma |
| Q38582323 | A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer |
| Q30466831 | A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers. |
| Q89996308 | Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma |
| Q55463263 | Alterations in the RB1 Pathway in Low‐grade Diffuse Gliomas Lacking Common Genetic Alterations |
| Q42173208 | Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo. |
| Q36963811 | Apoptosis regulators as targets for cancer therapy |
| Q41808889 | Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. |
| Q35088734 | Apoptotic cell signaling in cancer progression and therapy |
| Q36358595 | Arsenic trioxide rewires mantle cell lymphoma response to bortezomib |
| Q47616531 | Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement |
| Q52144774 | Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors |
| Q36935301 | BCL-2 family regulation by the 20S proteasome inhibitor bortezomib |
| Q60919518 | BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker |
| Q34085370 | BH3-only proteins in apoptosis and beyond: an overview |
| Q35883875 | BH3-only proteins in apoptosis at a glance |
| Q36463059 | BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. |
| Q47985820 | BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. |
| Q37373448 | Bcl2 family proteins in carcinogenesis and the treatment of cancer. |
| Q35737865 | Bim and Bmf in tissue homeostasis and malignant disease |
| Q35991973 | Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression |
| Q37132890 | Bortezomib: putting mantle cell lymphoma on death row. |
| Q33760917 | Bryostatin analogue-induced apoptosis in mantle cell lymphoma cell lines |
| Q36920817 | CREB-binding protein (CBP) regulates β-adrenoceptor (β-AR)-mediated apoptosis |
| Q33674213 | Cellular stress responses: cell survival and cell death |
| Q57261264 | Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia |
| Q35610374 | Chromosomal instability as a prognostic marker in cervical cancer |
| Q34041761 | Clinical significance of BIM deletion polymorphism in non-small-cell lung cancer with epidermal growth factor receptor mutation |
| Q35051842 | Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis |
| Q44994019 | Clonal heterogeneity of mantle cell lymphoma revealed by array comparative genomic hybridization |
| Q41836780 | Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM. |
| Q42111039 | Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK. |
| Q38172752 | Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. |
| Q57291791 | Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease |
| Q36774970 | Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis. |
| Q27486415 | Current Awareness on Comparative and Functional Genomics |
| Q28591851 | Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim |
| Q37921609 | Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases |
| Q35790266 | Defining ploidy-specific thresholds in array comparative genomic hybridization to improve the sensitivity of detection of single copy alterations in cell lines |
| Q36943634 | Detection of DNA copy number alterations in cancer by array comparative genomic hybridization |
| Q38782374 | Directly targeting the mitochondrial pathway of apoptosis for cancer therapy using BH3 mimetics - recent successes, current challenges and future promise. |
| Q39031250 | Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma |
| Q52655175 | Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis. |
| Q36529929 | Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature |
| Q39149974 | Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma |
| Q83289839 | Emerging role of Mcl-1 in actively counteracting BH3-only proteins in apoptosis |
| Q35608164 | Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice |
| Q36801093 | Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex. |
| Q33474807 | Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim |
| Q33654192 | Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities |
| Q38750145 | Expression of metastasis suppressor gene AES driven by a Yin Yang (YY) element in a CpG island promoter and transcription factor YY2. |
| Q36558024 | Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy |
| Q33925625 | Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth |
| Q34450467 | Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a |
| Q59606812 | Functional antagonism between pro-apoptotic BIM and anti-apoptotic BCL-XL in MYC-induced lymphomagenesis |
| Q33577390 | Gene bi-targeting by viral and human miRNAs |
| Q39819083 | Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia. |
| Q39190247 | Gene methylation and silencing of SOCS3 in mantle cell lymphoma |
| Q38303529 | Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization |
| Q27851412 | Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics |
| Q80306610 | Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma |
| Q40328303 | Genomewide array-based comparative genomic hybridization analysis of acute promyelocytic leukemia |
| Q40330626 | Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma |
| Q37269010 | Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma |
| Q37783548 | Genomic profiles in B cell lymphoma |
| Q40176023 | Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32. |
| Q42160424 | Glucose--a sweet way to die: metabolic switching modulates tumor cell death |
| Q36413767 | Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma |
| Q54538115 | High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia. |
| Q45775887 | High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival |
| Q37563700 | How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma? |
| Q33343257 | Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene |
| Q36498093 | Identification of miR-15b as a transformation-related factor in mantle cell lymphoma |
| Q38850384 | Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts. |
| Q39116343 | Impact of conditional deletion of the pro-apoptotic BCL-2 family member BIM in mice |
| Q36970689 | In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas |
| Q44114704 | Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma. |
| Q40392033 | Increased expression of Mcl-1 is required for protection against serum starvation in phosphatase and tensin homologue on chromosome 10 null mouse embryonic fibroblasts, but repression of Bim is favored in human glioblastomas |
| Q34192011 | Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development |
| Q38353509 | Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism |
| Q54389322 | Intratumoral heterogeneity of genomic imbalance in a case of epithelioid glioblastoma with BRAF V600E mutation |
| Q36294226 | Life in the balance: how BH3-only proteins induce apoptosis. |
| Q37217649 | MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs. |
| Q35848951 | MYC levels govern hematopoietic tumor type and latency in transgenic mice |
| Q37564773 | Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cells |
| Q44679554 | Mantle cell lymphoma: taking therapeutic advantage of new insights into the biology |
| Q33306334 | Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis |
| Q37166300 | MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways |
| Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
| Q37152738 | Molecular genetic characterization reveals new subsets of mantle cell lymphoma |
| Q37401338 | Molecular outcome prediction in mantle cell lymphoma |
| Q39949741 | Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques |
| Q34479078 | Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma |
| Q39993811 | Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways |
| Q28484910 | Oncogenic kit triggers Shp2/Erk1/2 pathway to down-regulate the pro-apoptotic protein Bim and to promote apoptosis resistance in leukemic cells |
| Q31164228 | Parallel gene expression profiling of mantle cell lymphoma - how do we transform 'omics data into clinical practice |
| Q34074921 | Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling |
| Q83587583 | Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling |
| Q34047859 | Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained |
| Q91474390 | Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma |
| Q39669154 | Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells |
| Q92698655 | Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma |
| Q34167987 | Prognostic impact of bim, puma, and noxa expression in human colon carcinomas. |
| Q41860419 | Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis |
| Q54593016 | Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas. |
| Q37272067 | RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice. |
| Q26781203 | Regulation of Bim in Health and Disease |
| Q79412060 | Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells |
| Q81833475 | Regulatory phosphorylation of Bim: sorting out the ERK from the JNK |
| Q34091061 | Responses in Mantle Cell Lymphoma Cells to SNS-032 Depend on the Biological Context of Each Cell Line |
| Q36403445 | Role of gga-miR-221 and gga-miR-222 during Tumour Formation in Chickens Infected by Subgroup J Avian Leukosis Virus |
| Q38095676 | Role of microRNA in the pathogenesis of malignant lymphoma. |
| Q36629194 | Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature |
| Q46118117 | Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma |
| Q50930237 | Subversion of the Bcl-2 life/death switch in cancer development and therapy. |
| Q39400792 | Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL |
| Q90317657 | T-cell receptor signal strength and epigenetic control of Bim predict memory CD8+ T-cell fate |
| Q53526225 | TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma |
| Q42175008 | Targeting Apoptosis Signaling Pathways for Anticancer Therapy |
| Q39456786 | Targeting BCL-2-like Proteins to Kill Cancer Cells |
| Q90047057 | Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer |
| Q36649225 | Targeting early B-cell receptor signaling induces apoptosis in leukemic mantle cell lymphoma. |
| Q60916539 | Targeting the Bcl-2 Family in B Cell Lymphoma |
| Q39575518 | Targeting the Regulatory Machinery of BIM for Cancer Therapy |
| Q36002501 | Targeting the absence: homozygous DNA deletions as immutable signposts for cancer therapy |
| Q47166330 | The BCL-2 arbiters of apoptosis and their growing role as cancer targets |
| Q36067778 | The BCL-2 protein family, BH3-mimetics and cancer therapy |
| Q27010154 | The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics |
| Q24620437 | The Bcl-2 apoptotic switch in cancer development and therapy |
| Q26797469 | The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential |
| Q34718167 | The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis |
| Q39221506 | The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects |
| Q37325443 | The curious case of the tumour virus: 50 years of Burkitt's lymphoma |
| Q35083049 | The essential role of evasion from cell death in cancer |
| Q39437383 | The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation |
| Q41489275 | The p53-Bcl-2 connection |
| Q42040698 | The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis |
| Q40985170 | The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells. |
| Q37854419 | The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy |
| Q38057709 | The role of the apoptotic machinery in tumor suppression |
| Q38715430 | Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies |
| Q36252762 | Tumor suppressor genetics |
| Q45401541 | Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. |
| Q37143660 | Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. |
| Q36364527 | Update on the molecular biology of mantle cell lymphoma |
| Q33780816 | Vinblastine induces acute, cell cycle phase-independent apoptosis in some leukemias and lymphomas and can induce acute apoptosis in others when Mcl-1 is suppressed |
| Q38115235 | XV. Malignant lymphoma as a consequence of clonal evolution |
| Q28306984 | betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis |
| Q43098314 | c-Cbl is not required for ERK1/2-dependent degradation of BimEL. |
| Q38780780 | miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis |
| Q40274693 | p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells |
Search more.